Assessment of Response of Unresectable Hepatocellular Carcinoma Chemoembolization and Stereotactic Body Radiation Therapy

ID Number 14-1671

Principal Investigator(s)
Michael Buckstein

Department(s) or Division(s)
Hematology and Medical Oncology

Description

The purpose of this study is to develop better ways to treat liver cancer, known as hepatocellular carcinoma or HCC, while it is still in the liver.  Many treatments exist to treat tumors in the liver when they are small but after they grow past a certain size, local therapies such as surgery, Trans-Arterial Chemo Embolization (TACE), or Radiofrequency Ablation (RFA) are not effective.  The purpose of this study is to test the combination of two known treatments - TACE and Stereotactic Body Radiation Therapy (SBRT) - to be used together to treat larger or difficult to access liver tumors.



Contact Information
Lynda Rath
(212) 824-7309

Recruiting Patients: Yes